GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orient Pharma Co Ltd (ROCO:4166) » Definitions » Inventory-to-Revenue

Orient Pharma Co (ROCO:4166) Inventory-to-Revenue : 0.45 (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Orient Pharma Co Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Orient Pharma Co's Average Total Inventories for the quarter that ended in Dec. 2024 was NT$276 Mil. Orient Pharma Co's Revenue for the six months ended in Dec. 2024 was NT$620 Mil. Orient Pharma Co's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.45.

Orient Pharma Co's Inventory-to-Revenue for the quarter that ended in Dec. 2024 increased from Jun. 2024 (0.42) to Jun. 2024 (0.45)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Orient Pharma Co's Days Inventory for the six months ended in Dec. 2024 was 165.68.

Inventory Turnover measures how fast the company turns over its inventory within a year. Orient Pharma Co's Inventory Turnover for the quarter that ended in Dec. 2024 was 1.10.


Orient Pharma Co Inventory-to-Revenue Historical Data

The historical data trend for Orient Pharma Co's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orient Pharma Co Inventory-to-Revenue Chart

Orient Pharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventory-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.32 0.34 0.24 0.21

Orient Pharma Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.46 0.47 0.42 0.45

Competitive Comparison of Orient Pharma Co's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Orient Pharma Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orient Pharma Co's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orient Pharma Co's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Orient Pharma Co's Inventory-to-Revenue falls into.


;
;

Orient Pharma Co Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Orient Pharma Co's Inventory-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Inventory-to-Revenue (A: Dec. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2023 ) + Total Inventories (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )
=( (233.972 + 279.555) / 2 ) / 1222.816
=256.7635 / 1222.816
=0.21

Orient Pharma Co's Inventory-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue (Q: Dec. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jun. 2024 ) + Total Inventories (Q: Dec. 2024 )) / count ) / Revenue (Q: Dec. 2024 )
=( (272.477 + 279.555) / 2 ) / 619.838
=276.016 / 619.838
=0.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orient Pharma Co  (ROCO:4166) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Orient Pharma Co's Days Inventory for the six months ended in Dec. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2024 )/Cost of Goods Sold (Q: Dec. 2024 )*Days in Period
=276.016/304.029*365 / 2
=165.68

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Orient Pharma Co's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2024 ) / Average Total Inventories (Q: Dec. 2024 )
=304.029 / 276.016
=1.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orient Pharma Co Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Orient Pharma Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Orient Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Kehu 1st Road, Huwei Town, Yunlin County, Central Science Park, Taipei, TWN, 106
Orient Pharma Co Ltd develops and manufactures pharmaceuticals. The company uses its platform technologies for the development of specialty pharmaceutical products and is capable of manufacturing products under cGMP. It provides drugs for treating Alzheimer's disease, psychostimulants, and treating Parkinson's disease.

Orient Pharma Co Headlines

No Headlines